Researchers in the U.K. develop urine test to measure patients’ adherence to hypertension meds

New research from the University of Leicester in the United Kingdom suggests that one in three people with high blood pressure fail to take their prescribed medications.

In the study, published in the journal Hypertension, investigators used a novel urine test to yield answers on whether patients were adhering to their prescribed medications. The study, which included 1,400 hypertensive patients, was led by Pankaj Gupta, MD, a researcher at Leicester.

Results showed that 30-40 percent of patients in the study did not adhere to medication regimens. The findings are concerning to physicians since non-adherence can lead to poorer cardiovascular outcomes and is estimated to cost the U.S. economy about $100 billion.

However, the urine test developed by the investigators, called liquid chromatography-tandem mass spectrometry, could be a method to ensure more patients adhere to their meds. The researchers have set up the National Centre for Adherence Testing at Leicester’s Hospitals and now receives samples from about 25 hypertension clinics across the U.K.

Through studying those samples, they’ve found that more than 41.6 percent of the U.K. cohort and 31.5 percent of the Czech Republic cohort were non-adherent to their anti-hypertensive medications. Additionally, 14.5 percent of the U.K. and 12 percent of the Czech cohorts weren’t taking any of their medications.

"Given the high prevalence of non-adherence, we should assess patients, particularly those on multiple antihypertensive medications or those who do not have an expected response to treatment,” Gupta said in a statement.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.